COVID-19: Autoantibodies can cause severe disease and deaths

Various studies have revealed that autoantibodies have been a key driver of severe illness and deaths amongst people critically infected with COVID-19. Findings also show that autoantibodies’ concentration in human bodies increases with age

WHO mega trial results out: Remdesivir, Interferon fail to prove effective

None of the four drug/drug combinations that were deployed in the WHO’s SOLIDARITY trial were found to be effective in reducing mortality, not even the much-hyped anti-viral drug Remdesivir